Technical analysis of Corbus Pharmaceuticals Holdings, Inc. (CRBP): price and volume charts, candlestick patterns, moving averages (SMA, EMA), RSI, MACD, ADX and Bollinger Bands. Identify momentum, trend direction and potential entry/exit zones.
Corbus Pharmaceuticals Holdings, Inc. is an oncology company, which engages in research, development, and commercializing therapeutics for cancer and obesity. Its pipeline includes CRB-701, an antibody drug conjugate (ADC) that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload, CRB-601, an anti-integrin monoclonal antibody that blocks the activation of TGFß expressed on cancer cells, and CRB-913, a highly peripherally restricted cannabinoid typ...
Price Performance
| 1 month | -27.98% |
| 3 months | -12.11% |
| Year-to-date | -10.81% |
| 1 year | -37.52% |
| 3 years | +2.25% |
| 5 years | -76.27% |
52-Week Range
| 52-week High | $20.56 |
| 52-week Low | $6.33 |
| Avg Volume (90d) | 664K |
Technical Indicators
| SMA 50 | $9.62 |
| SMA 200 | $9.16 |
| Beta | 2.79 |
| 30-day Volatility (annualised) | 85.3% |
| Price vs SMA 50 | -24.6% |
| Price vs SMA 200 | -20.8% |
Monthly Close (12 months)
| Month | Close | Change |
|---|
| 2025-10 | $12.15 | |
| 2025-11 | $11.54 | -5.0% |
| 2025-12 | $8.14 | -29.5% |
| 2026-01 | $8.27 | +1.6% |
| 2026-02 | $8.57 | +3.6% |
| 2026-03 | $9.39 | +9.6% |
| 2026-04 | $9.88 | +5.2% |
| 2026-05 | $7.91 | -19.9% |
| 2026-06 | $9.38 | +18.6% |
| 2026-07 | $8.97 | -4.4% |
| 2026-08 | $10.91 | +21.6% |
| 2026-09 | $7.26 | -33.5% |
Upcoming Earnings
| Date | EPS Est. | Revenue Est. |
|---|
| 2026-09-14 | | |
| 2026-09-14 | | |
| 2026-09-14 | | |
| 2026-09-14 | | |
| 2026-09-14 | | $144M |
| 2026-09-14 | | $898M |
Price
| Price | $7.26 |
| Market Cap | $135M |
| Exchange | NASDAQ |
| Country | US |
Valuation Ratios
| Price / Book | 1.40 |
| EV / EBITDA | -1.84 |
| Dividend Yield | 0.00% |
Financial Health
| Debt / Equity | 0.04 |
| Current Ratio | 5.71 |